Team:KAIT JAPAN

From 2014.igem.org

(Difference between revisions)

Latest revision as of 14:54, 16 October 2014

Home

Team

Project

Parts

Protocol

Notebook

Results

Safety

Human Practice

Welcome to KAIT JAPAN !

Our team started a new project !

The details are Project page.

News

9/1 Team OPEN!

9/1 Safety OPEN!

8/25 Protocol OPEN!

8/25 Notebook OPEN!

Contacts

‎[http://twitter.com/KAIT_JAPAN @KAIT_JAPAN]

[http://www.facebook.com/KAIT.Japan KAIT Japan]

[http://sites.google.com/site/kaitjapan/ KAIT Japan(Japanese)]

KAIT Japan

Sponsors

Project:Abstract
~Cure allergy system~

Acquired immune system is one of two main immunity strategies in vertebrates. In this system , Helper T cells work mainly. Th1 cells and Tｈ2 cells keep balance mutually, and two cells usually control immune response. When this balance collapses and became the Th2 predominance, IL-5 is secreted excessively from Th2, and eosonophil,basophil,and mast cells are activated by IL-5. These activated cells secrete inflammatory materials that cause allergic symptoms such as bronchial asthma and atopic dermatitis. On the other hand, by stimulation of IL-12, naïve T cell differentiates into Th1 cell and Th1 cell alleviates allergic symptoms. We though it is possible to ameliorate allergic symptoms by decreasing IL-5 and increasing IL-12. Focusing on ligand dependent dimerization of IL-5 receptor ,we try to make IL5 independent expression system .

@@ Line 1: / Line 1: @@
-{| style="width:98.5%; margin-left:0.2em; border-color:#f30; border-style:solid; border-collapse:collapse; background-color:#fc6; text-align:left"
+[[File:ロゴ2.png|left|link=https://igem.org/Team.cgi]]
-| style="width:25%" valign="top" |
+[[File:KAIT Japan2013 Kanako.png|link=http://www.kait.jp/index2.php]]
-https://static.igem.org/mediawiki/2014/2/2a/KAIT_Japan_home1.png<span style="color:#f30">[[Team:KAIT_Japan|Home]]</span>
+[[File:KAIT Japan 2014 iGEMRogo.png|center|link=https://2014.igem.org/Main_Page]]
-:[[Team:KAIT_Japan/Team|Team]]
+{|style= width="100%" align="center"
-:[[Team:KAIT_Japan/Project|Project]]
+|
-:[[Team:KAIT_Japan/Parts|Parts]]
+ {|style="background:#FFFFFF; margin:0.1em"
-:[[Team:KAIT_Japan/Protocol|Protocol]]
+!align="center"|[[File:New home t.jpg|link=Team:KAIT JAPAN]]
-:[[Team:KAIT_Japan/Notebook|Notebook]]
+[[Team:KAIT JAPAN|Home]]
-:[[Team:KAIT_Japan/Results|Results]]
+|}
-:[[Team:KAIT_Japan/Safety|Safety]]
+|
-:[[Team:KAIT_Japan/Human Practice|Human Practice]]
+{|style="background:#FFFFFF; margin:0.1em"
-------
+!align="center"|[[File:New Team1.jpg|link=Team:KAIT_Japan/Team]]
-<span style="color:#f30">'''Welcome to KAIT Japan!!'''</span>
+[[Team:KAIT_Japan/Team|Team]]
-:Project of this year is an '''allergy!'''
+|}
-<!-- end welcome box -->
+|
+{|style="background:#FFFFFF; margin:0.1em"
+!align="center"|[[File:New 考える人.jpg|link=Team:KAIT_Japan/Project]]
+[[Team:KAIT_Japan/Project|Project]]
+|}
+|
+{|style="background:#FFFFFF; margin:0.1em"
+!align="center"|[[File:New 歯車.jpg|link=Team:KAIT_Japan/Parts]]
+[[Team:KAIT_Japan/Parts|Parts]]
+|}
+|
+{|style="background:#FFFFFF; margin:0.1em"
+!align="center"|[[File:New １１１１１１１１１１１１１１１.jpg|link=Team:KAIT_Japan/Protocol]]
+[[Team:KAIT_Japan/Protocol|Protocol]]
+|}
+|
+{|style="background:#FFFFFF; margin:0.1em"
+!align="center"|[[File:Ff.jpg|link=Team:KAIT_Japan/Notebook]]
+[[Team:KAIT_Japan/Notebook|Notebook]]
+|}
+|
+{|style="background:#FFFFFF; margin:0.1em"
+!align="center"|[[File:New 結果.jpg|link=Team:KAIT_Japan/Results]]
+[[Team:KAIT_Japan/Results|Results]]
+|}
+|
+{|style="background:#FFFFFF; margin:0.1em"
+!align="center"|[[File:New new 危険.jpg|link=Team:KAIT_Japan/Safety]]
+[[Team:KAIT_Japan/Safety|Safety]]
+|}
+|
+{|style="background:#FFFFFF; margin:0.1em"
+!align="center"|[[File:New new ひと.jpg|link=Team:KAIT_Japan/Human_Practice]]
+[[Team:KAIT_Japan/Human_Practice|Human Practice]]
+|}
+|
+|}
+{| style="width:98.5%; margin-left:0.2em; border-color:#00BFFF; border-style:solid; border-collapse:collapse; background-color:#ffffe0; text-align:left"
+| style="width:30% style="vertical-align:top" |
+https://static.igem.org/mediawiki/2012/d/d6/KAIT_Japan-photo-side.jpg<br>
+<span style="color:#f33">'''Welcome to KAIT JAPAN !'''</span><br>
+<small>
+:Our team started a new project !<br>
+:The details are [[Team:KAIT_Japan/Project|Project page]].<br>
+</small>
 ------
 <span style="color:#f30">'''News'''</span>
+:9/1  Team <span style="color:#ff0000">'''OPEN!'''</span>
+:9/1  Safety <span style="color:#ff0000">'''OPEN!'''</span>
+:8/25 Protocol <span style="color:#ff0000">'''OPEN!'''</span>
+:8/25 Notebook <span style="color:#ff0000">'''OPEN!'''</span>
 ------
 <span style="color:#f30">'''Contacts'''</span>
@@ Line 28: / Line 74: @@
 <span style="color:#f30">'''Sponsors'''</span>
-| style="border-left:3px solid #f30" valign="top" |
+:[[File:KAIT_Japan_2014_Yume.png|link=http://www.kait.jp/yumepro/]]
-::https://static.igem.org/mediawiki/2013/1/17/KAIT_Japan2013_Achoo%21.png
-'''[[Team:KAIT_Japan/Project|Project]]:<span style="color:#f33">Abstract'''</span>
-<br>
-:<big>Hay fever curE.coli ~revenge~</big><br>
-<br>
+[[File:KAIT_Japan_2014_Cosmo.png|link=http://www.cosmobio.co.jp/index_e.asp]]
-:I looked back at the failure of last year. I think it tries to complete this plan this year. Japanese on of six people is troubled now by hay fever. These people take a medicine for its. But, If they take it , they become sleepy. So we are working on a project to relive hay fever by E.Coli to improve these. Mechanism of hay fever When an allergen invades it in the living body, naïve T cell differentiates in Th2. There is more Th2 than Th1, and the mast cell and others that is humoral immunity become active, and inflammation is in this way caused. We perform following four this time. ①Expression of IL-10 receptor to E.coli. ②Phosphorylation of STAT3. ③Preparation of gene array with HlyA and L-12 promoter and receiving the STAT3. ④Preparation of gene array with TolC and HlyB and HlyD promoter and to receive the STAT3.
-<P>
+| style="border-left:3px solid #00BFFF" valign="top" |
-::1. Expression of IL-10 receptor to E.coli.
+::https://static.igem.org/mediawiki/2013/1/17/KAIT_Japan2013_Achoo%21.png
+'''[[Team:KAIT_Japan/Project|Project]]:<span style="color:#f33">Abstract'''</span>
 <br>
-::2. Phosphorylation of STAT3.
+<font size="4">~Cure allergy system~</font>
-<br>
+Acquired immune system is one of two main immunity strategies in vertebrates.
-::3. Preparation of gene array with HlyA and L-12 promoter and receiving the STAT3.
+In this system , Helper T cells work mainly.
+Th1 cells and Tｈ2 cells keep balance mutually, and two cells usually control immune response. When this balance collapses and became the Th2 predominance, IL-5 is secreted excessively from Th2, and eosonophil,basophil,and mast cells are activated by IL-5. These activated cells secrete inflammatory materials that cause allergic symptoms such as bronchial asthma and atopic dermatitis. On the other hand, by stimulation of IL-12, naïve T cell differentiates into Th1 cell and Th1 cell alleviates allergic symptoms. We though it is possible to ameliorate allergic symptoms by decreasing IL-5 and increasing IL-12. Focusing on ligand dependent dimerization of IL-5 receptor ,we try to make IL5 independent expression system .
-<br>
-::4. Preparation of gene array with TolC and HlyB and HlyD promoter and to receive the STAT3.
-</P>
-<br>